A study has assessed the potential impact of the EU-US Transatlantic Trade and Investment Partnership (TTIP) on public health and health systems.
A study carried out by the London School of Economics and Political Science – with a grant from health organisations including IOGT International – has assessed the potential impact of the EU-US Transatlantic Trade and Investment Partnership (TTIP) on public health and health systems. TTIP negotiations are still ongoing, but on current evidence the study concludes that there is
very limited evidence of direct potential health benefits.
The study highlights potential concerns relating to the possible inclusion of investor protection provisions – the so called Investor State Dispute Settlement (ISDS) – noting that it may
negatively impact on the ability of government to regulate for public health improvement.
The LSE study analyses potential impact of TTIP on alcohol harm in Europe and Europe’s, governments’ ability to control alcohol through evidence-based measures.
Four points clearly outline the dangers and threats posed by the current TTIP agenda to evidence-based, high-impact alcohol policy-making.